Sort
17,054 grants matching “genome editing”
Characterizing the MSI2 network in leukemia
$392,583Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Multimodality Molecular Imaging of Stem Cell Therapy for Ischemic Cardiomyopathy
$392,582Patricia Kim Phuong Nguyen · Stanford University · R01 · FY2018 · HL
Multimodality Molecular Imaging of Stem Cell Therapy for Ischemic Cardiomyopathy
$392,576Patricia Kim Phuong Nguyen · Stanford University · R01 · FY2017 · HL
CRISPR-Image Core
$392,536Adam David Hoppe · South Dakota State University · P20 · FY2025 · GM
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems
$392,500Jennifer A Doudna · University Of California Berkeley · U01 · FY2019 · AI
Combinatorial Actions of Genetic Variants and Gender Bias of Alzheimer's Disease
$392,500Michael G Rosenfeld · University Of California, San Diego · R01 · FY2018 · AG
Transcriptional Regulation of Cone Photoreceptor Genesis
$392,500Mark M Emerson · City College Of New York · R01 · FY2023 · EY
Transcriptional Regulation of Cone Photoreceptor Genesis
$392,500Mark M Emerson · City College Of New York · R01 · FY2020 · EY
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems
$392,500Jennifer A Doudna · University Of California Berkeley · U01 · FY2020 · AI
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems
$392,500Jennifer A Doudna · University Of California Berkeley · U01 · FY2022 · AI
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems
$392,500Jennifer A Doudna · University Of California Berkeley · U01 · FY2018 · AI
Kinase Multitargeting for Glaucoma Neuroprotection
$392,500Derek Stuart Welsbie · University Of California, San Diego · R01 · FY2018 · EY
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems
$392,500Jennifer A Doudna · University Of California Berkeley · U01 · FY2021 · AI
UC Irvine AD Translational Center for Disease Model Resources-Lipid and Energy Metabolism in MODEL-AD Supplement
$392,500Frank M Laferla · University Of California-Irvine · U54 · FY2020 · AG
Off-the-shelf iPSC-Derived Natural Killer Cell Immunotherapies for AML
$392,480Jeffrey S Miller · University Of Minnesota · P01 · FY2025 · CA
Biodegradable nanoparticles, a genome editing platform to treat hemophilia
$392,468Yizhou Dong · Ohio State University · R01 · FY2018 · HL
Causes and functional consequences of chromatin evolution
$392,111Mia Tauna Levine · University Of Pennsylvania · R35 · FY2019 · GM
Causes and functional consequences of chromatin evolution
$392,111Mia Tauna Levine · University Of Pennsylvania · R35 · FY2018 · GM
Causes and functional consequences of chromatin evolution
$392,111Mia Tauna Levine · University Of Pennsylvania · R35 · FY2020 · GM
Causes and functional consequences of chromatin evolution
$392,111Mia Tauna Levine · University Of Pennsylvania · R35 · FY2021 · GM
Project 1: Role of the H3K27 demethylase KDM6A in bladder cancer pathogenesis
$391,906David B. Solit · Columbia University Health Sciences · P01 · FY2020 · CA
Project 1: Role of the H3K27 demethylase KDM6A in bladder cancer pathogenesis
$391,905David B. Solit · Columbia University Health Sciences · P01 · FY2021 · CA
Bioinformatics Strategies for Genome-Wide Association Studies
$391,879Jason H. Moore · University Of Pennsylvania · R01 · FY2021 · LM
Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapy
$391,721Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2025 · CA
Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapy
$391,721Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2022 · CA